Dilemma of Tocilizumab therapy for a patient with critical COVID‐19 disease and neutropenia: Case report and review of the literature

Dilemma of Tocilizumab therapy for a patient with critical COVID‐19 disease and neutropenia: Case report and review of the literature

Abstract Infection following SARS‐Co V‐2 leading to COVID‐19 disease is associated with significant morbidity and mortality. The clinical entity, COVID‐19 cytokine storm syndrome (CSS) is a severe immunological manifestation of the disease associated with ominous consequences. Tocilizumab is interle...

Full description

Bibliographic Details
Main Authors: Ahmad Al Bishawi, Shiema Abdalla, Marwa Askar, Wael Kanjo, Amal Sameer, Gihan Mustafa, Hamad Abdel Hadi, Muna Al Maslamani, Alaaeldin Abdelmajid
Format: Article
Language:English
Published: Wiley 2022-05-01
Series:Clinical Case Reports
Subjects:
COVID‐19
cytokine storm
Filgrastim
interleukin 6
neutropenia
tocilizumab
Online Access:https://doi.org/10.1002/ccr3.5932

Internet

https://doi.org/10.1002/ccr3.5932

Similar Items